Zacks.com on MSN3h
NVS vs. LLY: Which Stock Is the Better Value Option?
Investors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard of Novartis (NVS) and Eli Lilly (LLY). But which of these two stocks is more attractive to value ...
Amgen Q3 Earnings Review: So Many Questions, But MariTide Data Top Of The List
Amgen Inc.'s Q3 earnings may not be a major upside, but new pipeline drugs and potential breakthroughs could drive growth.
Eli Lilly and Company (NYSE:LLY) Holdings Decreased by Grassi Investment Management
Grassi Investment Management lessened its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 0.2% in the ...
Eli Lilly and Company (NYSE:LLY) Shares Sold by Boyd Watterson Asset Management LLC OH
Boyd Watterson Asset Management LLC OH trimmed its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 9.3% during ...
Eli Lilly price target raised to $1,250 from $1,060 at Citi
Citi raised the firm’s price target on Eli Lilly (LLY) to $1,250 from $1,060 and keeps a Buy rating on the shares following a transfer of ...
Zacks.com on MSN6h
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know
Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
Eli Lilly Is Putting On Some Weight As Earnings Near
Eli Lilly and Company has shown rapid growth with significant revenue increases. Click here to find out why I've decided to ...